Matches in Nanopublications for { ?s ?p "[In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of ?-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of ?-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP354080.RAUx2qxXib2vCCW0Zn-mei3Wl_PxaoRvRvUdIt4KhB41E130_assertion description "[In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of ?-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354080.RAUx2qxXib2vCCW0Zn-mei3Wl_PxaoRvRvUdIt4KhB41E130_provenance.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion description "[In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of ?-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.